Global Rigid Endoscopic Lithotripsy Devices Market Size By Type (Ultrasonic Lithotripsy, Ballistic Lithotripsy), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Rigid Endoscopic Lithotripsy Devices Market Report Description

The Global Rigid Endoscopic Lithotripsy Devices Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.2 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031. The market is driven by the rising prevalence of urolithiasis globally, the increasing demand for minimally invasive urological procedures, and continuous advancements in rigid endoscopy technologies. The growing geriatric population and the rising incidence of kidney stones, particularly in regions with higher obesity and dietary risk factors, further contribute to the expansion of this market.

Drivers:

Increasing Incidence of Urolithiasis:

Rising prevalence of urinary tract stones due to dietary changes, dehydration, and lifestyle factors is fueling the demand for effective treatment options such as rigid endoscopic lithotripsy.

Shift Toward Minimally Invasive Procedures:

The medical industry’s transition toward minimally invasive surgeries, which reduce recovery time and hospital stays, supports the adoption of rigid endoscopic lithotripsy devices.

Technological Advancements:

Improved visualization, ergonomic design, and integration with energy sources like holmium lasers are enhancing treatment precision and outcomes, boosting the device uptake.

Restraints:

High Cost of Endoscopic Equipment:

The high initial investment and maintenance costs of rigid endoscopic systems and associated energy sources may limit adoption in cost-sensitive markets and smaller healthcare settings.

Risk of Ureteral Damage and Limitations:

Despite its efficacy, rigid endoscopy poses a higher risk of complications in specific anatomical areas and is less suitable for flexible navigation, limiting its use in complex stone locations.

Opportunity:

Growing Adoption in Emerging Markets:

Expanding healthcare infrastructure and increasing healthcare spending in countries such as India, Brazil, and China offer substantial growth potential for market participants.

Integration of Digital Imaging & Smart Technologies:

The adoption of digital imaging, integration with AI for real-time analytics, and enhanced optical clarity are revolutionizing endoscopic lithotripsy, offering new avenues for innovation and growth.

Market by System Type Insights:

The Holmium Laser-Based Lithotripsy devices segment accounted for the largest share in 2023. The segment benefits from high precision, minimal tissue damage, and effectiveness across various stone compositions. As hospitals increasingly invest in laser-enabled rigid endoscopy systems, this segment is expected to continue its dominance.

Market by End-Use Insights:

In 2023, the Hospitals segment held the highest market share, owing to the high availability of advanced surgical equipment, trained urologists, and reimbursement support in developed markets. Ambulatory Surgical Centers (ASCs) are anticipated to register the fastest growth due to increasing patient preference for outpatient procedures and lower treatment costs.

Market by Regional Insights:

North America dominated the market in 2023 due to advanced healthcare infrastructure, favorable reimbursement policies, and high awareness regarding minimally invasive urological procedures. However, Asia-Pacific is expected to witness the fastest CAGR during the forecast period, driven by rising healthcare investment, a growing patient pool, and increased access to advanced treatment technologies.

Competitive Scenario:

Leading players in the Global Rigid Endoscopic Lithotripsy Devices Market include Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Stryker Corporation, Richard Wolf GmbH, Cook Medical, and Coloplast Group. These companies are actively investing in R&D, expanding their product portfolios, and entering strategic collaborations to strengthen their global footprint.

Scope of Work – Global Rigid Endoscopic Lithotripsy Devices Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.2 billion

CAGR (2023–2031) 9.1%

Market Segments System Type, End-use, Region

Growth Drivers Rising urolithiasis incidence, minimally invasive surgical demand, and technological innovation

Opportunities Emerging markets, integration of AI and digital imaging

Key Market Developments:

2023: Olympus Corporation introduced a new line of high-definition rigid endoscopes integrated with narrow-band imaging for enhanced visualization in urology procedures.

2024: Boston Scientific launched a next-gen holmium laser lithotripsy platform with AI-assisted targeting for improved stone fragmentation efficiency.

2025: Karl Storz SE & Co. KG expanded its manufacturing capabilities in Asia to cater to the rising demand for rigid endoscopy equipment in emerging economies.

FAQs:

1. What is the current market size of the Global Rigid Endoscopic Lithotripsy Devices Market?

The market was valued at USD 1.1 billion in 2023.

2. What is the major growth driver of the Global Rigid Endoscopic Lithotripsy Devices Market?

The rising incidence of urolithiasis and growing demand for minimally invasive urological procedures are the major drivers.

3. Which is the largest region during the forecast period in the Global Rigid Endoscopic Lithotripsy Devices Market?

North America accounted for the largest share in 2023.

4. Which segment accounted for the largest market share in the Global Rigid Endoscopic Lithotripsy Devices Market?

The Holmium Laser-Based Lithotripsy segment held the largest share by system type.

5. Who are the key market players in the Global Rigid Endoscopic Lithotripsy Devices Market?

Key players include Boston Scientific, Olympus Corporation, Karl Storz, Stryker, and Richard Wolf GmbH.

Would you like this in a downloadable Word or PDF format?